{"id":12441,"date":"2018-09-28T17:20:53","date_gmt":"2018-09-28T17:20:53","guid":{"rendered":"https:\/\/www.tmc.edu\/news\/a-virus-with-no-vaccine-treatment-is-in-the-utmb-research-crosshairs\/"},"modified":"2019-08-16T15:04:28","modified_gmt":"2019-08-16T15:04:28","slug":"a-virus-with-no-vaccine-treatment-is-in-the-utmb-research-crosshairs","status":"publish","type":"post","link":"https:\/\/www.tmc.edu\/news\/2018\/09\/a-virus-with-no-vaccine-treatment-is-in-the-utmb-research-crosshairs\/","title":{"rendered":"A virus with no vaccine, treatment is in the UTMB research crosshairs"},"content":{"rendered":"
There is no vaccine and no antiviral treatment for it, but if you were to check, just about every two or three-year-old child in the U.S. has been infected by respiratory syncytial virus.<\/div>\n
<\/div>\n
While for many the virus, discovered in 1957 and known as RSV, will cause mild, cold-like symptoms, for some infants and older adults, an infection can cause hospitalization and, especially in developing countries, even result in death.<\/div>\n